Use IHC Assay First for HER2 in Esophageal Ca

SAN FRANCISCO (MedPage Today) -- Immunohistochemistry to assess HER2 status in esophageal cancer showed good sensitivity and specificity, suggesting potential to reserve a more costly test for indeterminate IHC results, according to a study reported here.

http://www.medpagetoday.com/MeetingCoverage/MGICS/37001

Source: MedPage Today Primary Care - January 25, 2013 Category: Primary Care Source Type: news